KatayounRezvaniMD

PubMed

• Improved survival with younger HLA-matched unrelated donors versus older matched sibling donor HCT with PTCy-prophylaxis.
  Jeremy Ramdial, Partow Kebriaei, Richard E Champlin, Uday Popat, Katayoun Rezvani, Elizabeth J Shpall, Rohtesh S Mehta> ;Leukemia. 2024 May 2
• Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
  Sairah Ahmed, Qaiser Bashir, Roland L Bassett Jr, Fauzia Ullah, Fleur Aung, Benigno C Valdez, Amin M Alousi, Chitra Hosing, Partow Kebriaei, Issa Khouri, David Marin, ...> ;American Journal of Hematology. 2024 Apr 1
• Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation.
  Curtis Marcoux, Rima M Saliba, Whitney Wallis, Sajad Khazal, Dristhi Ragoonanan, Gabriela Rondon, Priti Tewari, Uday Popat, Betul Oran, Amanda Olson, Qaiser Bashir, Mu...> ;Blood Advances. 2024 Mar 12
• Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis: a single-centre retrospective experience.
  Anthony Febres-Aldana, Fareed Khawaja, Oscar Morado-Aramburo, Terri Lynn Shigle, Gabriela Rondon, Joseph Sassine, Amy Spallone, Krithika Srinivasan, Jeremy Ramdial, Am...> ;Clinical Microbiology and Infection. 2024 Mar 8
• Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML.
  Stefan O Ciurea, Piyanuch Kongtim, Samer Srour, Julianne Chen, Doris Soebbing, Elizabeth Shpall, Katayoun Rezvani, Robin Nakkula, Aarohi Thakkar, Ella C Troy, Alex A C...> ;American Journal of Hematology. 2024 May 1
• 1 citations
  Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape.
  Ye Li, Rafet Basar, Guohui Wang, Enli Liu, Judy S Moyes, Li Li, Lucila N Kerbauy, Nadima Uprety, Mohsen Fathi, Ali Rezvan, Pinaki P Banerjee, Luis Muniz-Feliciano, Tam...> ;Nature Medicine. 2024 Mar 1
• 7 citations
  Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19B cell tumors: a phase 1/2 trial.
  David Marin, Ye Li, Rafet Basar, Hind Rafei, May Daher, Jinzhuang Dou, Vakul Mohanty, Merve Dede, Yago Nieto, Nadima Uprety, Sunil Acharya, Enli Liu, Jeffrey Wilson, P...> ;Nature Medicine. 2024 Mar 1
• Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents.
  Marques-Piubelli, M., Kumar, B., Basar, R., Panowski, S., Srinivasan, S., Norwood, K., Prashad, S., Szenes, V., Balakumaran, A., Arandhya, A., Lu, W., Khan, K., Duenas...> ;Virchows Archiv. 2024 Feb 22
• Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis.
  Malek, A., Al-Juhaishi, T., Milton, D., Ramdial, J., Daher, M., Olson, A., Srour, S., Alatrash, G., Oran, B., Mehta, R., Khouri, I., Bashir, Q., Shah, N., Ciurea, S., ...> ;Bone Marrow Transplantation. 2024 Feb 14
• 1 citations
  Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma.
  Daniel Kirschenbaum, Ken Xie, Florian Ingelfinger, Yonatan Katzenelenbogen, Kathleen Abadie, Thomas Look, Fadi Sheban, Truong San Phan, Baoguo Li, Pascale Zwicky, Ido ...> ;Cell. 2024 Jan 4
• Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin Lym...
  Nieto, Y., Banerjee, P., Kaur, I., Kim, K., Fang, D., Thall, P., Griffin, L., Barnett, M., Basar, R., Hosing, C., Ramdial, J., Srour, S., Daher, M., Marin, D., Jiang, ...> ;Transplantation and Cellular Therapy. 2024 Feb 1
• Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell Therapy.
  Esther Bachar-Lustig, Assaf Lask, Yaki Eidelstein, Noga Or-Geva, Rotem Gidron-Budovsky, Bar Nathansohn-Levy, Matthias Eyrich, Wei-Hsin Liu, Giang Dang, Karla Castro Mi...> ;Transplantation and Cellular Therapy. 2024 Jan 1
• 1 citations
  Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age.
  Rima M Saliba, Christopher G Kanakry, Shahinaz Gadalla, Partow Kebriaei, Katayoun Rezvani, Richard E Champlin, Elizabeth J Shpall, Daniel Weisdorf, Rohtesh S Mehta> ;American Journal of Hematology. 2024 Jan 1
• Hematopoietic cell transplantation can be safely performed after COVID-19.
  Alejandro Marinos, Jeremy Ramdial, Fareed Khawaja, Rima M Saliba, Terri Lynn Shigle, Amin M Alousi, Gabriela Rondon, Julianne Chen, Celina Ledesma, Richard E Champlin,...> ;Bone Marrow Transplantation. 2023 Dec 1
• 1 citations
  Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities.
  Uday R Popat, Oren Pasvolsky, Roland Bassett Jr, Rohtesh S Mehta, Amanda Olson, Julianne Chen, Amin M Alousi, Gheath Al-Atrash, Qaiser Bashir, Alison M Gulbis, Chitra ...> ;Blood Advances. 2023 Oct 24
• 7 citations
  Characterizing cancer metabolism from bulk and single-cell RNA-seq data using METAFlux.
  Yuefan Huang, Vakul Mohanty, Merve Dede, Kyle Tsai, May Daher, Li Li, Katayoun Rezvani, Ken Chen> ;Nature Communications. 2023 Aug 12
• 3 citations
  Next-generation chimeric antigen receptors for T- and natural killer-cell therapies against cancer.
  Ye Li, Katayoun Rezvani, Hind Rafei> ;Immunological Reviews. 2023 Nov 1
• 14 citations
  Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering.
  Li Li, Vakul Mohanty, Jinzhuang Dou, Yuefan Huang, Pinaki P Banerjee, Qi Miao, Jens G Lohr, Tushara Vijaykumar, Julia Frede, Birgit Knoechel, Luis Muniz-Feliciano, Tam...> ;Science Advances. 2023 Jul 28
• 2 citations
  Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022).
  Paolo A Ascierto, Antonio Avallone, Carlo Bifulco, Sergio Bracarda, Joshua D Brody, Leisha A Emens, Robert L Ferris, Silvia C Formenti, Omid Hamid, Douglas B Johnson, ...> ;Journal of Translational Medicine. 2023 Jul 20
• 5 citations
  Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation.
  Yaohua Zhang, Zilong Zhao, Lisa A Huang, Yuan Liu, Jun Yao, Chengcao Sun, Yajuan Li, Zhao Zhang, Youqiong Ye, Fei Yuan, Tina K Nguyen, Nikhil Reddy Garlapati, Andrew W...> ;Cell Metabolism. 2023 Aug 8
• 3 citations
  Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response.
  Mihnea P Dragomir, Enrique Fuentes-Mattei, Melanie Winkle, Keishi Okubo, Recep Bayraktar, Erik Knutsen, Aiham Qdaisat, Meng Chen, Yongfeng Li, Masayoshi Shimizu, Lan P...> ;The Journal of Clinical Investigation. 2023 Jul 17
• The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022.
  Paolo A Ascierto, Renier Brentjens, Samir N Khleif, Kunle Odunsi, Katayoun Rezvani, Marco Ruella, Ryan J Sullivan, Bernard A Fox, Igor Puzanov> ;Journal of Translational Medicine. 2023 Apr 22
• 2 citations
  Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cel...
  Rohtesh S Mehta, Jeremy Ramdial, David Marin, Amin Alousi, Christopher G Kanakry, Richard E Champlin, Katayoun Rezvani, Elizabeth J Shpall, Kristin Page, Shahinaz M Ga...> ;Transplantation and Cellular Therapy. 2023 Jun 1
• 4 citations
  Expanded NK cells used for adoptive cell therapy maintain diverse clonality and contain long-lived memory-like NK cell populations.
  David S J Allan, Chuanfeng Wu, Ryland D Mortlock, Mala Chakraborty, Katayoun Rezvani, Jan K Davidson-Moncada, Cynthia E Dunbar, Richard W Childs> ;Molecular Therapy Oncolytics. 2023 Mar 16
• 3 citations
  Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future.
  Gabriela Sanchez-Petitto, Katayoun Rezvani, May Daher, Hind Rafei, Partow Kebriaei, Elizabeth J Shpall, Amanda Olson> ;Stem Cells Translational Medicine. 2023 Mar 3
• Join now to see all

Journal Articles

• Use of CAR-Transduced NK Cells in CD19-Positive Lymphoid Tumors  
  Katayoun Rezvani, MD, The New England Journal of Medicine
• Management Guidelines for Paediatric Patients Receiving Chimeric Antigen Receptor T Cell Therapy  
  Kris M Mahadeo, Julie C Fitzgerald, Marie E Steiner, Partow Kebriaei, Katayoun Rezvani, Ira M Cheifetz, John M Slopis, Paul L Martin, Sattva S Neelapu, Agne Tarasevici..., Nature
• Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia  
  Oran B, Jorgensen JL, Marin D, Wang S, Ahmed S, Alousi AM, Andersson BS, Bashir Q, Bassett R, Lyons G, Chen J, Rezvani K, Popat U, Kebriaei P, Patel K, Rondon G, Shpal..., Haematologica, 1/1/2017
• A subset of virus-specific CD161(+) T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML  
  Alsuliman A, Muftuoglu M, Khoder A, Ahn YO, Basar R, Verneris MR, Muranski P, Barrett AJ, Liu E, Li L, Stringaris K, Armstrong-James D, Shaim H, Kondo K, Imahashi N, A..., Blood, 1/1/2017
• Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma  
  Shah N, Li L, McCarty J, Kaur I, Yvon E, Shaim H, Muftuoglu M, Liu E, Orlowski RZ, Cooper L, Lee D, Parmar S, Cao K, Sobieiski C, Saliba R, Hosing C, Ahmed S, Nieto Y,..., Br J Haematol, 1/1/2017
• Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning  
  Yucel OK, Saliba RM, Rondon G, Ahmed S, Alousi A, Bashir Q, Ciurea SO, Popat U, Khouri I, Marin D, Rezvani K, Kebriaei P, Shpall EJ, Champlin RE, Oran B, Cancer, 1/1/2017
• Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery  
  Mehta RS, Saliba RM, Cao K, Kaur I, Rezvani K, Chen J, Olson A, Parmar S, Shah N, Marin D, Alousi A, Hosing C, Popat U, Kebriaei P, Champlin R, de Lima M, Skerrett D, ..., Biol Blood Marrow Transplant, 1/1/2017
• Guidelines for the use of flow cytometry and cell sorting in immunological studies  
  Cossarizza A, Chang HD, Radbruch A, Akdis M, Andra I, Annunziato F, Bacher P, Barnaba V, Battistini L, Bauer WM, Baumgart S, Becher B, Beisker W, Berek C, Blanco A, Bo..., Eur J Immunol, 1/1/2017
• Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease  
  Khoder A, Alsuliman A, Basar R, Sobieski C, Kondo K, Alousi AM, Szydlo R, Muftuoglu M, Shaim H, Apperley JF, Gokdemir E, Cooper N, Mehta RS, Marin D, Champlin R, Shpal..., Front Immunol, 1/1/2017
• Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivo  
  Parmar S, Liu X, Najjar A, Shah N, Yang H, Yvon E, Rezvani K, McNiece I, Zweidler-McKay P, Miller L, Wolpe S, Blazar BR, Shpall EJ, Blood, 1/1/2015
• Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials  
  Mehta RS, Rezvani K, Olson A, Oran B, Hosing C, Shah N, Parmar S, Armitage S, Shpall EJ, Front Med, 1/1/2015
• Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease  
  Parmar S, Liu X, Tung SS, Robinson SN, Rodriguez G, Cooper LJ, Yang H, Shah N, Yang H, Konopleva M, Molldrem JJ, Garcia-Manero G, Najjar A, Yvon E, McNiece I, Rezvani ..., Cytotherapy, 1/1/2014
• Progress in novel cellular therapy options for chronic lymphocytic leukemia: the M D Anderson perspective  
  Shah N, Rezvani K, Hosing C, Kebriaei P, Wierda W, Cooper L, Shpall E, Clin Lymphoma Myeloma Leuk, 1/1/2014
• BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress  
  Zou J, Rezvani K, Wang H, Lee KS, Zhang D, Cell Cycle, 1/1/2013
• Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity  
  Shah N, Martin-Antonio B, Yang H, Ku S, Lee DA, Cooper LJ, Decker WK, Li S, Robinson SN, Sekine T, Parmar S, Gribben J, Wang M, Rezvani K, Yvon E, Najjar A, Burks J, K..., PLoS One, 1/1/2013
• BCR-ABL1 kinase domain mutations: methodology and clinical evaluation  
  Alikian M, Gerrard G, Subramanian PG, Mudge K, Foskett P, Khorashad JS, Lim AC, Marin D, Milojkovic D, Reid A, Rezvani K, Goldman J, Apperley J, Foroni L, Am J Hematol, 1/1/2012
• Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation  
  Chaidos A, Patterson S, Szydlo R, Chaudhry MS, Dazzi F, Kanfer E, McDonald D, Marin D, Milojkovic D, Pavlu J, Davis J, Rahemtulla A, Rezvani K, Goldman J, Roberts I, A..., Blood, 1/1/2012
• Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host  
  de Lavallade H, Garland P, Sekine T, Hoschler K, Marin D, Stringaris K, Loucaides E, Howe K, Szydlo R, Kanfer E, Macdonald D, Kelleher P, Cooper N, Khoder A, Gabriel I..., Haematologica, 1/1/2011
• Duplex quantitative PCR for molecular monitoring of BCR-ABL1-associated hematological malignancies  
  Gerrard G, Mudge K, Stewart R, Foskett P, Stevens D, Khorashad JS, Szydlo R, Rezvani K, Marin D, Reid A, Apperley J, Goldman J, Foroni L, Am J Hematol, 1/1/2011
• Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies  
  Rezvani K, Yong AS, Mielke S, Jafarpour B, Savani BN, Le RQ, Eniafe R, Musse L, Boss C, Kurlander R, Barrett AJ, Haematologica, 1/1/2011
• Improving outcomes in myeloid leukemia patients: does a new DNA vaccine hold the answer?  
  Rezvani K, de Lavallade H, Expert Rev Vaccines, 1/1/2011
• Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in...  
  Mielke S, McIver ZA, Shenoy A, Fellowes V, Khuu H, Stroncek DF, Leitman SF, Childs R, Battiwalla M, Koklanaris E, Haggerty J, Savani BN, Rezvani K, Barrett AJ, Biol Blood Marrow Transplant, 1/1/2011
• Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib  
  Marin D, Bazeos A, Mahon FX, Eliasson L, Milojkovic D, Bua M, Apperley JF, Szydlo R, Desai R, Kozlowski K, Paliompeis C, Latham V, Foroni L, Molimard M, Reid A, Rezvan..., J Clin Oncol, 1/1/2010
• UBXD4, a UBX-containing protein, regulates the cell surface number and stability of alpha3-containing nicotinic acetylcholine receptors  
  Rezvani K, Teng Y, Pan Y, Dani JA, Lindstrom J, Garc�a Gras EA, McIntosh JM, De Biasi M, J Neurosci, 1/1/2009
• The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib  
  Khorashad JS, Wagner S, Greener L, Marin D, Reid A, Milojkovic D, Patel H, Willimott S, Rezvani K, Gerrard G, Loaiza S, Davis J, Goldman J, Melo J, Apperley J, Foroni L, Haematologica, 1/1/2009
• Join now to see all

Books/Book Chapters

• Advanced Laboratory Methods in Haematology 
  Chapter: ISCH- The Measurement of Serum Vitamin B 12, Serum Folate and Red Cell Folate 
  Wickramasinghe SN, Rezvani K2002

Abstracts/Posters

• Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Next Generation CRISPR Gene-Edited and Off-the-Shelf Virus-Specific T-Cells for the Immunocompromised Patient
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi...
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Blinatumomab Is Well Tolerated Maintenance Therapy Following Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Combining CAR Engineering and CIS Checkpoint Deletion in NK Cells for the Treatment of B Cell Hematologic Malignancies
  Katayoun Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS
  Katy Rezvani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Hematopoietic Stem Cell Transplantation
  Rezvani K, Blood; Highlights of ASH in North America, Atlanta, GA, 2017; Seattle, WA, 2017, 1/27/2017
• Allogeneic Transplantation for TP53+ AML: Prognostic Factors for Survival
  Stefan O. Ciurea, Rima M. Saliba, Julianne Chen, Gabriela Rondon, Uday Popat, Simrit Parmar, Borge Anderson, Amin M. Alousi, Sairah Ahmed, Qaiser Bashir, Gheath Alatra..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Cord Blood NK Cells Engineered to Express a Humanized CD123-Targeted Chimeric Antigen Receptor (CAR) and IL-15 As Off-the-Shelf Therapy for Acute Myeloid Leukemia
  Lucila Nassif Kerbauy, Sonny Ang, Enli Liu, Pinaki P Banerjee, Yewen Wu, Hila Shaim, Francesca Lorraine Wei Inng Lim, Rafet Basar, Li Li, Muharrem Muftuoglu, May Daher..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• CS1-Specific Chimeric Antigen Receptor Drives Cord Blood NK Cell Maturation and Expansion In Vivo
  Li Li, Muharrem Muftuoglu, Enli Liu, Sonny Ang, Jiangxing Lv, Xinhai Wan, Rong Cai, Han Chen, Bingqian Hu, Juan Jimenez, Duncan Mak, Jared K Burks, Mustafa H Bdiwi, Pi..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Early Maintenance with Tyrosine Kinase Inhibitors Post Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Improves Survival in Ph+ Acute Lymphoblastic Leukemia ...
  Lohith Gowda, Majdi Alijadayeh, David Costa Marin, Celina Ledesma, Gabriela Rondon, Uday Popat, Amin M. Alousi, Betul Oran, Mithun Vinod Shah, Sairah Ahmed, Rashmi Kan..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Evaluation of T Cell Compartment By Mass Cytometry Reveals Distinct Patterns of Expression of Exhaustion Markers in Chronic Lymphocytic Leukemia
  Muharrem Muftuoglu, Li Li, Duncan Mak, Jared K Burks, Yuanxin Xi, Bingqian Hu, Hila Shaim, Nobuhiko Imahashi, Mustafa H Bdiwi, Juan Jimenez, Pinaki P Banerjee, Frances..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Exploring the Cord Blood T Cell Compartment with Mass Cytometry Reveals the Existence of Memory CD4, CD8 and Regulatory T Cell Pools in the Fetal Period
  Muharrem Muftuoglu, Li Li, Juan Jimenez, Duncan Mak, Jared K Burks, Bingqian Hu, Hila Shaim, Nobuhiko Imahashi, Francesca Lorraine Wei Inng Lim, Pinaki P Banerjee, Mus..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Graft Failure Post Allogeneic Stem Cell Transplant: Conditioning Regimen Improves Engraftment and Survival
  Lohith Gowda, Rima M. Saliba, Mithun Vinod Shah, Gabriela Rondon, Irfa Badar, Amanda L. Olson, Stefan O. Ciurea, Partow Kebriaei, Samer A. Srour, Simrit Parmar, Yago N..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Interim Results of a Phase 2 Clinical Trial Using Mb-IL21 Ex Vivo Expanded NK Cells to Enhance Graft Versus Leukemia Effect for Patients with Myeloid Malignancies afte...
  Stefan O. Ciurea, Doris Soebbing, Gabriela Rondon, Kai Cao, Gheath Alatrash, Sairah Ahmed, Uday Popat, Betul Oran, Qaiser Bashir, Partow Kebriaei, Indreshpal Kaur, Kat..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Large-Scale, Bioreactor-Generated Expansion of Umbilical Cord Blood Tissue-Derived Mesenchymal Stromal Cells for Clinical Use
  April DePombo, Ana Huertas-Herrera, Mayela Carolina Mendt, Francesca Lorraine Wei Inng Lim, Young Gi, Yijiu Tong, Indreshpal Kaur, May Daher, Rafet Basar, Hila Shaim, ..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Long Term Follow up after Adoptive Transfer of CD19-Specific CAR+ T Cells Genetically Modified Via Non-Viral Sleeping Beauty S ystem Following Hematopoietic Stem Cell ...
  Partow Kebriaei, Helen Huls, Simon Olivares, Aaron F Orozco, Shihuang Su, Sourindra N Maiti, Elenanor De Groot, Amy Smith, Yijun Yang, Gabriela Rondon, Muzaffar H. Qaz..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• NK Cell Diversity Influences Outcomes after Cord Blood Transplantation
  Li Li, Muharrem Muftuoglu, Han Chen, Duncan Mak, Jared K Burks, Rohtesh S. Mehta, Yuanxin Xi, Jiangxing Lv, Bingqian Hu, Juan Jimenez, Mecit Kaplan, Hila Shaim, Nobuhi..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Post-Transplant Cyclophosphamide Improves Progression Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients with Prior CTLA-4 or P...
  Betul Oran, Guillermo Garcia-Manero, Rima M. Saliba, Gheath Alatrash, Elias J. Jabbour, Uday Popat, Farhad Ravandi, Amin M. Alousi, Tapan Kadia, Marina Konopleva, Cour..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Shortening the Time to Manufacture CAR+ T Cells with Sleeping Beauty System Supports T-Cell Engraftment and Anti-Tumor Effects in Patients with Refractory CD19+ Tumors
  Partow Kebriaei, Helen Huls, Susan Lynn Neel, Simon Olivares, Aaron F Orozco, Shihuang Su, Sourindra N Maiti, Amy Smith, Elenanor De Groot, Hagop M. Kantarjian, Maro O..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• The Prognostic Impact of Minimal Residual Disease on Risk of Progression and Progression Free Survival in Acute Myeloid Leukemia
  Betul Oran, Rima M. Saliba, Jeffrey L. Jorgensen, Mithun Vinod Shah, David Costa Marin, Sa A. Wang, Sairah Ahmed, Amin M. Alousi, Borje S Andersson, Qaiser Bashir, Ste..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• The TGF-Beta/SMAD Signaling Pathway As a Mediator of NK Cell Dysfunction and Immune Evasion in Myelodysplastic Syndrome
  May Daher, Rafet Basar, Hila Shaim, Elif Gokdemir, Nadima Uprety, Alexander Kontoyiannis, Mayela Carolina Mendt, Nobuhiko Imahashi, Lucila Nassif Kerbauy, Francesca Lo..., Blood; American Society of Hematology, Atlanta, GA, 1/1/2017
• Can We Make a Better Match Using KIR Genotyping?
  Rezvani K, Blood; American Society of Hematology, San Diego, CA, 1/3/2016
• Join now to see all

Lectures

• Engineering natural killer cells for cancer immunotherapy 
  Tel Aviv, Israel - 1/1/2018
• Cord Blood NK cells to treat cancer 
  Weizmann Institute of Science, Israel - 1/1/2018
• Combined CAR-T Congress 
  Berlin, Germany - 1/1/2018
• NK-CARs - Vive La Difference CLL Global Alliance 
  Houston, TX - 1/1/2018
• The application of CAR-NK cells for the treatment of cancer 
  University of Leeds, Leeds, United Kingdom - 1/1/2018
• The FACTs about CARTOX: Immune Effector Cell Therapy Accreditation 
  Salt Lake City, UT - 1/1/2018
• Engineered NK cells for the treatment of cancer 
  Lisbon, Portugal - 1/1/2018
• Transforming Medicine with Cell Therapy 
  1/1/2018
• Off-the-shelf engineered NK cells 
  Montreal, Canada - 1/1/2018
• First-in-human trial of CAR-NK cells 
  Austin, TX - 1/1/2018
• Cellular Therapy in Glioblastoma 
  1/1/2018
• CAR-NK Cells: can they compete with CAR-T in immunooncology 
  Berlin, Germany - 1/1/2018
• CAR-T/Cellular Therapy -Clinical Update 
  Salt Lake City, UT - 1/1/2018
• Off-the-shelf CAR-engineered cord blood-derived NK cells for the treatment of cancer � the first-in-human trial 
  Chennai, India - 1/1/2018
• Engineered cord blood NK cells: the first in human trial 
  Lisbon, Portugal - 1/1/2018
• Off-the-shelf CAR-engineered cord blood-derived NK cells for the treatment of cancer- the first-in-human trial 
  San Diego, CA - 1/1/2018
• Immunotherapy: Virus specific lymphocytes for prevention and treatment of Infection 
  Albert Einstein Research and Education Institute, Sao Paulo, Brazil - 1/1/2018
• Cell therapy with CAR T and CAR NK: an alternative treatment 
  Albert Einstein Research and Education Institute, Sao Paulo, Brazil - 1/1/2018
• KIR/HLA immunogenetics in allogeneic hematopoietic stem cell transplant 
  Galveston, TX - 1/29/2017
• Post CBT immune interventions 
  Marseille, France - 1/27/2017
• Manufacturing of immune effector cells from umbilical cord products 
  1/26/2017
• CAR-Engineered Cord Blood NK Cells as a Source of Off-the-Shelf Cellular Therapy 
  San Diego, CA - 1/26/2017
• Genetically engineered cord blood NK cells as an of-the-shelf source of immunotherapy for cancer 
  Memorial Sloan Kettering Cancer Center, New York, NY - 1/1/2017
• Application of viral specific T cell therapy in transplantation 
  UT MD�Anderson Cancer Center, Houston, TX - 1/1/2017
• Off-the-shelf engineered NK cells for the treatment of cancer 
  Houston, TX - 1/1/2017
• Join now to see all